Showing 388 results

Filters Content type: News, Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP science

On-Demand Versus Daily PrEP May Mitigate TDF’s Effect on Kidneys, Reports French Study

Editor's pick
TheBodyPro
28 December 2023
Resistance

History of PrEP Use Linked to M184I/V Mutation at HIV Diagnosis

Editor's pick
Infectious Disease Advisor
22 December 2023
Antibody-based prevention

Oral tenofovir/FTC increases clearance of bNAb VRC01: implications for future research

Editor's pick
i-Base
4 December 2023
PrEP programmes & uptake

Is on-demand PrEP too demanding? Australian men’s experiences

News
17 November 2023
PrEP science

Cabotegravir Safe and Effective for Pre-Exposure Prophylaxis in Transgender Women, Global Study Finds

Editor's pick
TheBodyPro
30 October 2023
PrEP science

PrEP use in pregnancy doesn't raise the risk of adverse pregnancy or birth outcomes

News
22 September 2023
PrEP science

Users of TAF in PrEP more likely to develop high blood pressure or need statins

News
14 September 2023
The search for an HIV prevention vaccine

A trial is underway that could be ‘the last roll of the dice’ for an HIV vaccine this decade

Editor's pick
CNN
28 August 2023
PrEP science

Exposure to tenofovir-based PrEP in the womb does not affect children’s bone density

News
10 August 2023
PrEP programmes & uptake

Poorer adherence and higher HIV incidence among event-driven PrEP users in West African study

News
6 July 2023
PrEP science

Enemas, suppositories, and inserts are acceptable for applying HIV-prevention medicine before anal sex

News
23 June 2023
PrEP science

Adherence Support Needed for MSM Choosing On-Demand PrEP, West African Study Reports

Editor's pick
TheBodyPro
5 June 2023
PrEP science

Oral PrEP Is Effective for Women, but Only if They Take it Consistently

Editor's pick
POZ
23 May 2023
The search for an HIV prevention vaccine

It’s Time to End AIDS: Why EU Should Fund Search for HIV Vaccine

Editor's pick
Health Policy Watch
19 May 2023
PrEP science

As few as two PrEP pills a week protect during anal sex – but vaginal sex may need daily dosing

News
19 April 2023
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and PrEP from CROI 2023

News
15 March 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
PrEP science

HIV infections acquired while on injectable PrEP may take a very long time to be spotted

News
27 February 2023
Vaginal rings & topical PrEP

Promising new PrEP method undergoes first safety study for anal sex

News
24 February 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
Sexually transmitted infections prevention

Vaccine halves gonorrhoea rate in French study

News
20 February 2023
PrEP programmes & uptake

Preexposure Prophylaxis Gives Good Results in Latin America

Editor's pick
Medscape (requires free registration)
23 January 2023